Oxford to assess revolutionary multi-cancer blood test in trial, for future implementation in the NHS
A partnership between the University of Oxford and GRAIL, LLC will evaluate the use of a new, non-invasive, multi-cancer early detection test known as Galleri in suspected cancer patients. The national SYMPLIFY study aims to demonstrate this revolutionary technology can benefit patients and detect many cancers earlier. Ultimately Galleri could be used in routine visits […]